Fabienne Mazerolles
French Institute of Health and Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fabienne Mazerolles.
Archive | 1989
A Fischer; Barbara Lisowska-Grospierre; F. Le Deist; M. T. Dimanche; Fabienne Mazerolles; P. H. Trung
Impaired chemotaxis of phagocytic cells has been observed in a group of children who were suffering from recurrent bacterial infections (Anderson et al. 1987; Fischer et al. 1988). It has been later recognized that a membrane glycoprotein was missing on patients leukocytes. This defect was identified as a lack of the leukocyte adhesion molecules LFA-1, Mac-1 and pl50,95 (Springer et al. 1984).
Archive | 1990
A Fischer; Barbara Lisowska-Grospierre; Fabienne Mazerolles; F. Le Deist; N. Perez; M. T. Dimanche-Boitrel; C. Griscelli
In the past years, a new inherited immunodeficiency has been identified and been named the leukocyte adhesion deficiency (LAD) (1). Leukocyte adhesion deficiency is characterized by a defective expression of three related leukocyte adhesion molecules, i.e., LFA-1, Mac-1, and p150,95 which are heterodimers, the α chain being specific and the β chain common to the three molecules.
Journal of Crohns & Colitis | 2018
Fabienne Charbit-Henrion; Marianna Parlato; Sylvain Hanein; Rémi Duclaux-Loras; Jan Nowak; Bernadette Bègue; Sabine Rakotobe; Julie Bruneau; Cécile Fourrage; Olivier Alibeu; Frédéric Rieux-Laucat; Eva Lévy; Marie-Claude Stolzenberg; Fabienne Mazerolles; Sylvain Latour; Christelle Lenoir; Alain Fischer; Capucine Picard; Marina Aloi; Jorge Amil Dias; Mongi Ben Hariz; Anne Bourrier; Christian Breuer; Anne Breton; Jiri Bronski; Stephan Buderus; Mara Cananzi; S. Coopman; Clara Crémilleux; Alain Dabadie
Abstract Background and Aims An expanding number of monogenic defects have been identified as causative of severe forms of very early-onset inflammatory bowel diseases [VEO-IBD]. The present study aimed at defining how next-generation sequencing [NGS] methods can be used to improve identification of known molecular diagnosis and to adapt treatment. Methods A total of 207 children were recruited in 45 paediatric centres through an international collaborative network [ESPGHAN GENIUS working group] with a clinical presentation of severe VEO-IBD [n = 185] or an anamnesis suggestive of a monogenic disorder [n = 22]. Patients were divided at inclusion into three phenotypic subsets: predominantly small bowel inflammation, colitis with perianal lesions, and colitis only. Methods to obtain molecular diagnosis included functional tests followed by specific Sanger sequencing, custom-made targeted NGS, and in selected cases whole exome sequencing [WES] of parents-child trios. Genetic findings were validated clinically and/or functionally. Results Molecular diagnosis was achieved in 66/207 children [32%]: 61% with small bowel inflammation, 39% with colitis and perianal lesions, and 18% with colitis only. Targeted NGS pinpointed gene mutations causative of atypical presentations, and identified large exonic copy number variations previously missed by WES. Conclusions Our results lead us to propose an optimised diagnostic strategy to identify known monogenic causes of severe IBD.
Frontiers in Immunology | 2018
Fabienne Mazerolles; Marie-Claude Stolzenberg; Olivier Pellé; Capucine Picard; Bénédicte Neven; Alain Fischer; Aude Magerus-Chatinet; Frédéric Rieux-Laucat
Objective Autoimmune lymphoproliferative syndrome (ALPS) with FAS mutation (ALPS-FAS) is a nonmalignant, noninfectious, lymphoproliferative disease with autoimmunity. Given the central role of natural regulatory T cells (nTregs) in the control of lymphoproliferation and autoimmunity, we assessed nTreg-suppressive function in 16 patients with ALPS-FAS. Results The proportion of CD25highCD127low Tregs was lower in ALPS-FAS patients than in healthy controls. This subset was correlated with a reduced CD25 expression in CD3+CD4+ T cells from ALPS patients and thus an abnormally low proportion of CD25highFOXP3+ Helios+ T cells. The ALPS patients also displayed a high proportion of naïve Treg (FOXP3lowCD45RA+) and an unusual subpopulation (CD4+CD127lowCD15s+CD45RA+). Despite this abnormal phenotype, the CD25highCD127low Tregs’ suppressive function was unaffected. Furthermore, conventional T cells from FAS-mutated patients showed normal levels of sensitivity to Treg suppression. Conclusion An abnormal Treg phenotype is observed in circulating lymphocytes of ALPS patients. However, these Tregs displayed a normal suppressive function on T effector proliferation in vitro. This is suggesting that lymphoproliferation observed in ALPS patients does not result from Tregs functional defect or T effector cells insensitivity to Tregs suppression.
European Journal of Immunology | 1988
Fabienne Mazerolles; Catherine Lumbroso; Olivia Lecomte; Françoise Le Deist; Alain Fischer
European Journal of Immunology | 1990
Fabienne Mazerolles; François Amblard; Catherine Lumbroso; Olivia Lecomte; Pierre-François van de Moortele; Christiane Barbat; Dominique Piatier-Tonneau; Charles Auffray; Alain Fischer
Journal of Immunology | 1996
Fabienne Mazerolles; C Barbat; Claire Hivroz; A Fischer
The Journal of Allergy and Clinical Immunology | 2013
Fabienne Mazerolles; Capucine Picard; Sven Kracker; Alain Fischer; Anne Durandy
Journal of Immunology | 1991
J Corado; Fabienne Mazerolles; F. Le Deist; C Barbat; M Kaczorek; A Fischer
European Journal of Immunology | 1991
Fabienne Mazerolles; Pascale Hauss; Christiane Barbat; Carl G. Figdor; Alain Fischer